Information about Femara (Letrozole)
Femara is an aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which can help slow or stop the growth of certain types of breast tumors that require estrogen to grow.
Product Highlights
- As an adjuvant therapy for postmenopausal women with hormone receptor-positive early breast cancer.
- For the treatment of advanced breast cancer in postmenopausal women who have received prior anti-estrogen therapy.
Key Ingredient
Key Benefits
- Clinical studies have shown that Femara can significantly reduce the risk of breast cancer recurrence.
- Generally well-accepted by patients, with manageable side effects compared to other treatments.
- Once-daily administration simplifies treatment regimens.
Direction of Use
- Femara should be taken as prescribed, with or without food.
- It’s important to swallow the tablet whole, avoiding any crushing or chewing.
Safety Concerns
- Hot flashes, joint discomfort, fatigue, and nausea.
- Potential for osteoporosis and fractures due to reduced estrogen levels; cardiovascular risks should also be considered.
- Regular monitoring of bone density and overall health may be necessary.
Avoid Femara (Letrozole) If
- You have a known hypersensitivity to letrozole or any component of the formulation.
- You are pregnant or breastfeeding.
- You have premenopausal breast cancer or are not postmenopausal.
- You have a history of significant liver impairment.
